FLANC:一种新型灵长类特异性长链非编码RNA在结直肠癌中的治疗潜力
该研究在349例肿瘤样本中分析FLANC表达,并在体内外模型中探究其生物学功能与治疗潜力。FLANC在结直肠癌细胞中显著上调且高表达与不良生存相关,靶向FLANC可减少小鼠转移且无明显毒性。
要点
- FLANC在结直肠癌细胞中显著上调,高表达与不良生存相关。
- FLANC通过上调并延长磷酸化STAT3半衰期,诱导VEGFA过表达。
- 靶向FLANC的siRNA纳米颗粒可减少小鼠转移,无明显毒性。
核心结论
- FLANC是一种在结直肠癌细胞中高度上调并调控转移形成的新型灵长类特异性lncRNA。
- 靶向FLANC等灵长类特异性转录本可能成为低毒性的结直肠癌治疗新策略。
研究设计与样本
- 分析四个队列共349例肿瘤的FLANC表达并与临床数据关联。
- 利用系列体内外模型和分子分析表征FLANC的生物学功能。
- 在小鼠结直肠癌转移模型中探索靶向FLANC的治疗潜力。
主要发现
- 在两个独立队列中,FLANC在癌细胞中较正常结肠样本显著上调。
- 在两个额外独立结直肠癌患者队列中,高FLANC水平与不良生存相关。
- 体内外实验显示调节FLANC表达影响结直肠癌细胞的生长、凋亡、迁移、血管生成和转移形成能力。
- 机制上FLANC上调并延长磷酸化STAT3半衰期,诱导血管生成关键调控因子VEGFA过表达。
关键数值与推荐
- 通过1,2-二油酰-sn-甘油-3-磷脂酰胆碱纳米颗粒负载特异性小干扰RNA进行体内药理靶向FLANC,诱导转移显著减少,且无 evident 组织毒性或促炎效应。
临床怎么用
- FLANC高表达与结直肠癌不良生存相关,可能作为预后生物标志物。
- 靶向FLANC的纳米颗粒-siRNA策略在小鼠模型中减少转移且低毒,提示潜在治疗转化方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the function of a novel primate-specific long non-coding RNA (lncRNA), named FLANC, based on its genomic location (co-localised with a pyknon motif), and to characterise its potential as a biomarker and therapeutic target. DESIGN: FLANC expression was analysed in 349 tumours from four cohorts and correlated to clinical data. In a series of multiple in vitro and in vivo models and molecular analyses, we characterised the fundamental biological roles of this lncRNA. We further explored the therapeutic potential of targeting FLANC in a mouse model of colorectal cancer (CRC) metastases. RESULTS: FLANC, a primate-specific lncRNA feebly expressed in normal colon cells, was significantly upregulated in cancer cells compared with normal colon samples in two independent cohorts. High levels of FLANC were associated with poor survival in two additional independent CRC patient cohorts. Both in vitro and in vivo experiments demonstrated that the modulation of FLANC expression influenced cellular growth, apoptosis, migration, angiogenesis and metastases formation ability of CRC cells. In vivo pharmacological targeting of FLANC by administration of 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine nanoparticles loaded with a specific small interfering RNA, induced significant decrease in metastases, without evident tissue toxicity or pro-inflammatory effects. Mechanistically, FLANC upregulated and prolonged the half-life of phosphorylated STAT3, inducing the overexpression of VEGFA, a key regulator of angiogenesis. CONCLUSIONS: Based on our findings, we discovered, FLANC as a novel primate-specific lncRNA that is highly upregulated in CRC cells and regulates metastases formation. Targeting primate-specific transcripts such as FLANC may represent a novel and low toxic therapeutic strategy for the treatment of patients.
引用
- Pichler M, Rodriguez-Aguayo C, Nam SY, et al. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020. PMID: 31988194. doi:10.1136/gutjnl-2019-318903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。